Extensive unorganized PSA testing in the Nordic countries has led to significant increases in incidence from the 1990s [14], and PSA levels [15, 16] and the risk of metastatic disease at the time of diagnosis have decreased thereafter [16, 17]. This evidence concerns the gene KLK3 and metastatic neoplasm.